0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Children's Antipyretic Medicine Market Research Report 2025
Published Date: 2025-12-23
|
Report Code: QYRE-Auto-17L18337
Home | Market Reports | Health| Pharmacy
Global Children s Antipyretic Medicine Market Research Report 2024
BUY CHAPTERS

Global Children's Antipyretic Medicine Market Research Report 2025

Code: QYRE-Auto-17L18337
Report
2025-12-23
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Children's Antipyretic Medicine Market Size

The global market for Children's Antipyretic Medicine was valued at US$ 15330 million in the year 2024 and is projected to reach a revised size of US$ 17690 million by 2031, growing at a CAGR of 2.1% during the forecast period.

Children's Antipyretic Medicine Market

Children's Antipyretic Medicine Market

Children's antipyretics are drugs designed specifically for children to relieve fever symptoms. When giving children antipyretics, parents need to pay special attention to the type, dosage, and method of use of the drug.
North American market for Children's Antipyretic Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Children's Antipyretic Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Children's Antipyretic Medicine include Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children's Antipyretic Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children's Antipyretic Medicine.
The Children's Antipyretic Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Children's Antipyretic Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Children's Antipyretic Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Children's Antipyretic Medicine Market Report

Report Metric Details
Report Name Children's Antipyretic Medicine Market
Accounted market size in year US$ 15330 million
Forecasted market size in 2031 US$ 17690 million
CAGR 2.1%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Acetaminophen
  • Ibuprofen
  • Other
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang, Changshu Huagang
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Children's Antipyretic Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Children's Antipyretic Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Children's Antipyretic Medicine Market growing?

Ans: The Children's Antipyretic Medicine Market witnessing a CAGR of 2.1% during the forecast period 2026-2031.

What is the Children's Antipyretic Medicine Market size in 2031?

Ans: The Children's Antipyretic Medicine Market size in 2031 will be US$ 17690 million.

Who are the main players in the Children's Antipyretic Medicine Market report?

Ans: The main players in the Children's Antipyretic Medicine Market are Xinhua Pharmaceutical, IOLCP, Granules Biocause, Strides Shasun, Mallinckrodt, Farmson, Granules India, SKPL, Atabay, Temad, Anqiu Lu'an, Zhejiang Kangle, Hebei Jiheng, Novacyl, Anhui Fubore, Anhui BBCA Likang, Changshu Huagang

What are the Application segmentation covered in the Children's Antipyretic Medicine Market report?

Ans: The Applications covered in the Children's Antipyretic Medicine Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Children's Antipyretic Medicine Market report?

Ans: The Types covered in the Children's Antipyretic Medicine Market report are Acetaminophen, Ibuprofen, Other

1 Children's Antipyretic Medicine Market Overview
1.1 Product Definition
1.2 Children's Antipyretic Medicine by Type
1.2.1 Global Children's Antipyretic Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Acetaminophen
1.2.3 Ibuprofen
1.2.4 Other
1.3 Children's Antipyretic Medicine by Application
1.3.1 Global Children's Antipyretic Medicine Market Value by Application (2024 VS 2031)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Children's Antipyretic Medicine Market Size Estimates and Forecasts
1.4.1 Global Children's Antipyretic Medicine Revenue 2020-2031
1.4.2 Global Children's Antipyretic Medicine Sales 2020-2031
1.4.3 Global Children's Antipyretic Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Children's Antipyretic Medicine Market Competition by Manufacturers
2.1 Global Children's Antipyretic Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Children's Antipyretic Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Children's Antipyretic Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Children's Antipyretic Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Children's Antipyretic Medicine, Product Type & Application
2.7 Global Key Manufacturers of Children's Antipyretic Medicine, Date of Enter into This Industry
2.8 Global Children's Antipyretic Medicine Market Competitive Situation and Trends
2.8.1 Global Children's Antipyretic Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Children's Antipyretic Medicine Players Market Share by Revenue
2.8.3 Global Children's Antipyretic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Children's Antipyretic Medicine Market Scenario by Region
3.1 Global Children's Antipyretic Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Children's Antipyretic Medicine Sales by Region: 2020-2031
3.2.1 Global Children's Antipyretic Medicine Sales by Region: 2020-2025
3.2.2 Global Children's Antipyretic Medicine Sales by Region: 2026-2031
3.3 Global Children's Antipyretic Medicine Revenue by Region: 2020-2031
3.3.1 Global Children's Antipyretic Medicine Revenue by Region: 2020-2025
3.3.2 Global Children's Antipyretic Medicine Revenue by Region: 2026-2031
3.4 North America Children's Antipyretic Medicine Market Facts & Figures by Country
3.4.1 North America Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Children's Antipyretic Medicine Sales by Country (2020-2031)
3.4.3 North America Children's Antipyretic Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Children's Antipyretic Medicine Market Facts & Figures by Country
3.5.1 Europe Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Children's Antipyretic Medicine Sales by Country (2020-2031)
3.5.3 Europe Children's Antipyretic Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Children's Antipyretic Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Children's Antipyretic Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Children's Antipyretic Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Children's Antipyretic Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Children's Antipyretic Medicine Market Facts & Figures by Country
3.7.1 Latin America Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Children's Antipyretic Medicine Sales by Country (2020-2031)
3.7.3 Latin America Children's Antipyretic Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Children's Antipyretic Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Children's Antipyretic Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Children's Antipyretic Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Children's Antipyretic Medicine Sales by Type (2020-2031)
4.1.1 Global Children's Antipyretic Medicine Sales by Type (2020-2025)
4.1.2 Global Children's Antipyretic Medicine Sales by Type (2026-2031)
4.1.3 Global Children's Antipyretic Medicine Sales Market Share by Type (2020-2031)
4.2 Global Children's Antipyretic Medicine Revenue by Type (2020-2031)
4.2.1 Global Children's Antipyretic Medicine Revenue by Type (2020-2025)
4.2.2 Global Children's Antipyretic Medicine Revenue by Type (2026-2031)
4.2.3 Global Children's Antipyretic Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Children's Antipyretic Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Children's Antipyretic Medicine Sales by Application (2020-2031)
5.1.1 Global Children's Antipyretic Medicine Sales by Application (2020-2025)
5.1.2 Global Children's Antipyretic Medicine Sales by Application (2026-2031)
5.1.3 Global Children's Antipyretic Medicine Sales Market Share by Application (2020-2031)
5.2 Global Children's Antipyretic Medicine Revenue by Application (2020-2031)
5.2.1 Global Children's Antipyretic Medicine Revenue by Application (2020-2025)
5.2.2 Global Children's Antipyretic Medicine Revenue by Application (2026-2031)
5.2.3 Global Children's Antipyretic Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Children's Antipyretic Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Xinhua Pharmaceutical
6.1.1 Xinhua Pharmaceutical Company Information
6.1.2 Xinhua Pharmaceutical Description and Business Overview
6.1.3 Xinhua Pharmaceutical Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Xinhua Pharmaceutical Children's Antipyretic Medicine Product Portfolio
6.1.5 Xinhua Pharmaceutical Recent Developments/Updates
6.2 IOLCP
6.2.1 IOLCP Company Information
6.2.2 IOLCP Description and Business Overview
6.2.3 IOLCP Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 IOLCP Children's Antipyretic Medicine Product Portfolio
6.2.5 IOLCP Recent Developments/Updates
6.3 Granules Biocause
6.3.1 Granules Biocause Company Information
6.3.2 Granules Biocause Description and Business Overview
6.3.3 Granules Biocause Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Granules Biocause Children's Antipyretic Medicine Product Portfolio
6.3.5 Granules Biocause Recent Developments/Updates
6.4 Strides Shasun
6.4.1 Strides Shasun Company Information
6.4.2 Strides Shasun Description and Business Overview
6.4.3 Strides Shasun Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Strides Shasun Children's Antipyretic Medicine Product Portfolio
6.4.5 Strides Shasun Recent Developments/Updates
6.5 Mallinckrodt
6.5.1 Mallinckrodt Company Information
6.5.2 Mallinckrodt Description and Business Overview
6.5.3 Mallinckrodt Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Mallinckrodt Children's Antipyretic Medicine Product Portfolio
6.5.5 Mallinckrodt Recent Developments/Updates
6.6 Farmson
6.6.1 Farmson Company Information
6.6.2 Farmson Description and Business Overview
6.6.3 Farmson Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Farmson Children's Antipyretic Medicine Product Portfolio
6.6.5 Farmson Recent Developments/Updates
6.7 Granules India
6.7.1 Granules India Company Information
6.7.2 Granules India Description and Business Overview
6.7.3 Granules India Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Granules India Children's Antipyretic Medicine Product Portfolio
6.7.5 Granules India Recent Developments/Updates
6.8 SKPL
6.8.1 SKPL Company Information
6.8.2 SKPL Description and Business Overview
6.8.3 SKPL Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 SKPL Children's Antipyretic Medicine Product Portfolio
6.8.5 SKPL Recent Developments/Updates
6.9 Atabay
6.9.1 Atabay Company Information
6.9.2 Atabay Description and Business Overview
6.9.3 Atabay Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Atabay Children's Antipyretic Medicine Product Portfolio
6.9.5 Atabay Recent Developments/Updates
6.10 Temad
6.10.1 Temad Company Information
6.10.2 Temad Description and Business Overview
6.10.3 Temad Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Temad Children's Antipyretic Medicine Product Portfolio
6.10.5 Temad Recent Developments/Updates
6.11 Anqiu Lu'an
6.11.1 Anqiu Lu'an Company Information
6.11.2 Anqiu Lu'an Description and Business Overview
6.11.3 Anqiu Lu'an Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Anqiu Lu'an Children's Antipyretic Medicine Product Portfolio
6.11.5 Anqiu Lu'an Recent Developments/Updates
6.12 Zhejiang Kangle
6.12.1 Zhejiang Kangle Company Information
6.12.2 Zhejiang Kangle Description and Business Overview
6.12.3 Zhejiang Kangle Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Kangle Children's Antipyretic Medicine Product Portfolio
6.12.5 Zhejiang Kangle Recent Developments/Updates
6.13 Hebei Jiheng
6.13.1 Hebei Jiheng Company Information
6.13.2 Hebei Jiheng Description and Business Overview
6.13.3 Hebei Jiheng Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hebei Jiheng Children's Antipyretic Medicine Product Portfolio
6.13.5 Hebei Jiheng Recent Developments/Updates
6.14 Novacyl
6.14.1 Novacyl Company Information
6.14.2 Novacyl Description and Business Overview
6.14.3 Novacyl Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Novacyl Children's Antipyretic Medicine Product Portfolio
6.14.5 Novacyl Recent Developments/Updates
6.15 Anhui Fubore
6.15.1 Anhui Fubore Company Information
6.15.2 Anhui Fubore Description and Business Overview
6.15.3 Anhui Fubore Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Anhui Fubore Children's Antipyretic Medicine Product Portfolio
6.15.5 Anhui Fubore Recent Developments/Updates
6.16 Anhui BBCA Likang
6.16.1 Anhui BBCA Likang Company Information
6.16.2 Anhui BBCA Likang Description and Business Overview
6.16.3 Anhui BBCA Likang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Anhui BBCA Likang Children's Antipyretic Medicine Product Portfolio
6.16.5 Anhui BBCA Likang Recent Developments/Updates
6.17 Changshu Huagang
6.17.1 Changshu Huagang Company Information
6.17.2 Changshu Huagang Description and Business Overview
6.17.3 Changshu Huagang Children's Antipyretic Medicine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Changshu Huagang Children's Antipyretic Medicine Product Portfolio
6.17.5 Changshu Huagang Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Children's Antipyretic Medicine Industry Chain Analysis
7.2 Children's Antipyretic Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Children's Antipyretic Medicine Production Mode & Process Analysis
7.4 Children's Antipyretic Medicine Sales and Marketing
7.4.1 Children's Antipyretic Medicine Sales Channels
7.4.2 Children's Antipyretic Medicine Distributors
7.5 Children's Antipyretic Medicine Customer Analysis
8 Children's Antipyretic Medicine Market Dynamics
8.1 Children's Antipyretic Medicine Industry Trends
8.2 Children's Antipyretic Medicine Market Drivers
8.3 Children's Antipyretic Medicine Market Challenges
8.4 Children's Antipyretic Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Children's Antipyretic Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Children's Antipyretic Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Children's Antipyretic Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Children's Antipyretic Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Children's Antipyretic Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Children's Antipyretic Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Children's Antipyretic Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Children's Antipyretic Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Children's Antipyretic Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Children's Antipyretic Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Children's Antipyretic Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Children's Antipyretic Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Children's Antipyretic Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children's Antipyretic Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Children's Antipyretic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Children's Antipyretic Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Children's Antipyretic Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Children's Antipyretic Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Children's Antipyretic Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Children's Antipyretic Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Children's Antipyretic Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Children's Antipyretic Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Children's Antipyretic Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Children's Antipyretic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Children's Antipyretic Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Children's Antipyretic Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Children's Antipyretic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Children's Antipyretic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Children's Antipyretic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Children's Antipyretic Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Children's Antipyretic Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Children's Antipyretic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Children's Antipyretic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Children's Antipyretic Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Children's Antipyretic Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Children's Antipyretic Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Children's Antipyretic Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Children's Antipyretic Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Children's Antipyretic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Children's Antipyretic Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Children's Antipyretic Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Children's Antipyretic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Children's Antipyretic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Children's Antipyretic Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Children's Antipyretic Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Children's Antipyretic Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Children's Antipyretic Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Children's Antipyretic Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Children's Antipyretic Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Children's Antipyretic Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Children's Antipyretic Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Children's Antipyretic Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Children's Antipyretic Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Children's Antipyretic Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Children's Antipyretic Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Children's Antipyretic Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Children's Antipyretic Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Children's Antipyretic Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Children's Antipyretic Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Children's Antipyretic Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Children's Antipyretic Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Children's Antipyretic Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Children's Antipyretic Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Children's Antipyretic Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Children's Antipyretic Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Children's Antipyretic Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Children's Antipyretic Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. Xinhua Pharmaceutical Company Information
 Table 71. Xinhua Pharmaceutical Description and Business Overview
 Table 72. Xinhua Pharmaceutical Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Xinhua Pharmaceutical Children's Antipyretic Medicine Product
 Table 74. Xinhua Pharmaceutical Recent Developments/Updates
 Table 75. IOLCP Company Information
 Table 76. IOLCP Description and Business Overview
 Table 77. IOLCP Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. IOLCP Children's Antipyretic Medicine Product
 Table 79. IOLCP Recent Developments/Updates
 Table 80. Granules Biocause Company Information
 Table 81. Granules Biocause Description and Business Overview
 Table 82. Granules Biocause Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Granules Biocause Children's Antipyretic Medicine Product
 Table 84. Granules Biocause Recent Developments/Updates
 Table 85. Strides Shasun Company Information
 Table 86. Strides Shasun Description and Business Overview
 Table 87. Strides Shasun Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Strides Shasun Children's Antipyretic Medicine Product
 Table 89. Strides Shasun Recent Developments/Updates
 Table 90. Mallinckrodt Company Information
 Table 91. Mallinckrodt Description and Business Overview
 Table 92. Mallinckrodt Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Mallinckrodt Children's Antipyretic Medicine Product
 Table 94. Mallinckrodt Recent Developments/Updates
 Table 95. Farmson Company Information
 Table 96. Farmson Description and Business Overview
 Table 97. Farmson Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Farmson Children's Antipyretic Medicine Product
 Table 99. Farmson Recent Developments/Updates
 Table 100. Granules India Company Information
 Table 101. Granules India Description and Business Overview
 Table 102. Granules India Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Granules India Children's Antipyretic Medicine Product
 Table 104. Granules India Recent Developments/Updates
 Table 105. SKPL Company Information
 Table 106. SKPL Description and Business Overview
 Table 107. SKPL Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. SKPL Children's Antipyretic Medicine Product
 Table 109. SKPL Recent Developments/Updates
 Table 110. Atabay Company Information
 Table 111. Atabay Description and Business Overview
 Table 112. Atabay Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Atabay Children's Antipyretic Medicine Product
 Table 114. Atabay Recent Developments/Updates
 Table 115. Temad Company Information
 Table 116. Temad Description and Business Overview
 Table 117. Temad Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Temad Children's Antipyretic Medicine Product
 Table 119. Temad Recent Developments/Updates
 Table 120. Anqiu Lu'an Company Information
 Table 121. Anqiu Lu'an Description and Business Overview
 Table 122. Anqiu Lu'an Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Anqiu Lu'an Children's Antipyretic Medicine Product
 Table 124. Anqiu Lu'an Recent Developments/Updates
 Table 125. Zhejiang Kangle Company Information
 Table 126. Zhejiang Kangle Description and Business Overview
 Table 127. Zhejiang Kangle Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Zhejiang Kangle Children's Antipyretic Medicine Product
 Table 129. Zhejiang Kangle Recent Developments/Updates
 Table 130. Hebei Jiheng Company Information
 Table 131. Hebei Jiheng Description and Business Overview
 Table 132. Hebei Jiheng Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hebei Jiheng Children's Antipyretic Medicine Product
 Table 134. Hebei Jiheng Recent Developments/Updates
 Table 135. Novacyl Company Information
 Table 136. Novacyl Description and Business Overview
 Table 137. Novacyl Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Novacyl Children's Antipyretic Medicine Product
 Table 139. Novacyl Recent Developments/Updates
 Table 140. Anhui Fubore Company Information
 Table 141. Anhui Fubore Description and Business Overview
 Table 142. Anhui Fubore Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Anhui Fubore Children's Antipyretic Medicine Product
 Table 144. Anhui Fubore Recent Developments/Updates
 Table 145. Anhui BBCA Likang Company Information
 Table 146. Anhui BBCA Likang Description and Business Overview
 Table 147. Anhui BBCA Likang Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Anhui BBCA Likang Children's Antipyretic Medicine Product
 Table 149. Anhui BBCA Likang Recent Developments/Updates
 Table 150. Changshu Huagang Company Information
 Table 151. Changshu Huagang Description and Business Overview
 Table 152. Changshu Huagang Children's Antipyretic Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Changshu Huagang Children's Antipyretic Medicine Product
 Table 154. Changshu Huagang Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Children's Antipyretic Medicine Distributors List
 Table 158. Children's Antipyretic Medicine Customers List
 Table 159. Children's Antipyretic Medicine Market Trends
 Table 160. Children's Antipyretic Medicine Market Drivers
 Table 161. Children's Antipyretic Medicine Market Challenges
 Table 162. Children's Antipyretic Medicine Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Children's Antipyretic Medicine
 Figure 2. Global Children's Antipyretic Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Children's Antipyretic Medicine Market Share by Type: 2024 & 2031
 Figure 4. Acetaminophen Product Picture
 Figure 5. Ibuprofen Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Children's Antipyretic Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Children's Antipyretic Medicine Market Share by Application: 2024 & 2031
 Figure 9. Online Sales
 Figure 10. Offline Sales
 Figure 11. Global Children's Antipyretic Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Children's Antipyretic Medicine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Children's Antipyretic Medicine Sales (2020-2031) & (K Units)
 Figure 14. Global Children's Antipyretic Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Children's Antipyretic Medicine Report Years Considered
 Figure 16. Children's Antipyretic Medicine Sales Share by Manufacturers in 2024
 Figure 17. Global Children's Antipyretic Medicine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Children's Antipyretic Medicine Players: Market Share by Revenue in Children's Antipyretic Medicine in 2024
 Figure 19. Children's Antipyretic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Children's Antipyretic Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Children's Antipyretic Medicine Sales Market Share by Country (2020-2031)
 Figure 22. North America Children's Antipyretic Medicine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Children's Antipyretic Medicine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Children's Antipyretic Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Children's Antipyretic Medicine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Children's Antipyretic Medicine Revenue Market Share by Region (2020-2031)
 Figure 34. China Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Children's Antipyretic Medicine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Children's Antipyretic Medicine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Colombia Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Children's Antipyretic Medicine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Children's Antipyretic Medicine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Children's Antipyretic Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Children's Antipyretic Medicine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Children's Antipyretic Medicine by Type (2020-2031)
 Figure 54. Global Children's Antipyretic Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Children's Antipyretic Medicine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Children's Antipyretic Medicine by Application (2020-2031)
 Figure 57. Global Children's Antipyretic Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Children's Antipyretic Medicine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc